Andrew V Thillainayagam
Overview
Explore the profile of Andrew V Thillainayagam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coda S, Siersema P, Stamp G, Thillainayagam A
Endosc Int Open
. 2015 Nov;
3(5):E380-92.
PMID: 26528489
Detection, characterization, and staging constitute the fundamental elements in the endoscopic diagnosis of gastrointestinal diseases, but histology still remains the diagnostic gold standard. New developments in endoscopic techniques may challenge...
2.
Zakeri N, Coda S, Webster S, Howson W, Thillainayagam A
Frontline Gastroenterol
. 2015 Oct;
6(4):270-277.
PMID: 26500755
Objective: Conscious sedation is widely used in endoscopic practice but is not without risk. We aimed to determine the frequency of sedation complications requiring reversal, and to identify potential patient...
3.
G Ladep N, Dona A, Lewis M, Crossey M, Lemoine M, Okeke E, et al.
Hepatology
. 2014 Jun;
60(4):1291-301.
PMID: 24923488
Unlabelled: There is no clinically applicable biomarker for surveillance of hepatocellular carcinoma (HCC), because the sensitivity of serum alpha-fetoprotein (AFP) is too low for this purpose. Here, we determined the...
4.
Coda S, Thillainayagam A
Clin Exp Gastroenterol
. 2014 May;
7:133-50.
PMID: 24868168
Ideally, endoscopists should be able to detect, characterize, and confirm the nature of a lesion at the bedside, minimizing uncertainties and targeting biopsies and resections only where necessary. However, under...
5.
G Ladep N, Khan S, Crossey M, Thillainayagam A, Taylor-Robinson S, Toledano M
World J Gastroenterol
. 2014 Mar;
20(6):1544-53.
PMID: 24587630
Aim: To explore recent trends, modes of diagnosis, ethnic distribution and the mortality to incidence ratio of primary liver cancer by subtypes in England and Wales. Methods: We obtained incidence...
6.
Coda S, Thompson A, Kennedy G, Roche K, Ayaru L, Bansi D, et al.
Biomed Opt Express
. 2014 Feb;
5(2):515-38.
PMID: 24575345
We present an ex vivo study of temporally and spectrally resolved autofluorescence in a total of 47 endoscopic excision biopsy/resection specimens from colon, using pulsed excitation laser sources operating at...
7.
Reinisch W, Staun M, Tandon R, Altorjay I, Thillainayagam A, Gratzer C, et al.
Am J Gastroenterol
. 2013 Oct;
108(12):1877-88.
PMID: 24145678
Objectives: In the largest head-to-head comparison between an oral and an intravenous (IV) iron compound in patients with inflammatory bowel disease (IBD) so far, we strived to determine whether IV...
8.
Khan S, Davidson B, Goldin R, Heaton N, Karani J, Pereira S, et al.
Gut
. 2012 Aug;
61(12):1657-69.
PMID: 22895392
The British Society of Gastroenterology guidelines on the management of cholangiocarcinoma were originally published in 2002. This is the first update since then and is based on a comprehensive review...
9.
Zabron A, Horneffer-van der Sluis V, Wadsworth C, Laird F, Gierula M, Thillainayagam A, et al.
Am J Gastroenterol
. 2011 Jun;
106(9):1711-7.
PMID: 21670771
Objectives: Accurate differentiation between benign and malignant causes of biliary obstruction remains challenging and reliable biomarkers are urgently needed. Bile is a potential source of such biomarkers. Our aim was...
10.
Hashim Abdalla M, Taylor-Robinson S, Sharif A, Williams H, Crossey M, Badra G, et al.
HPB (Oxford)
. 2011 May;
13(6):385-90.
PMID: 21609370
Background: Cholangiocarcinoma (CC) is a fatal malignancy, the incidence of which is increasing worldwide, with substantial regional variation. Current diagnostic techniques to distinguish benign from malignant biliary disease are unsatisfactory....